Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by floatinketuckyon Jan 28, 2022 12:52pm
310 Views
Post# 34372045

$TLTFF 10 year range breaker.

$TLTFF 10 year range breaker. $TLTFF AFTERBURNER
FDA PHONE CALLS
BTD AA

30 PATIENTS TREATED WITH 20 TO 25 FOR BTD.

TLTFF MANAGED THE COVID CIRCUMSTANCE TREE NICELY.. Well done zippin through that curve guys!!!

WELL DONE BOYS WITH THAT. BUT WAIT

THE CURVY ROAD OF THE 30 PERCENT WAS THE
DISCRESCTION OF THE PRINCIPAL INVESTIGATOR. Looks like investors missed what was going on all along. It was all most like The PI sayin.. darn after that ph 1.. Lets dial it back for the firs dozen at a 70 percent dose and see. then mop up with the 2nd dose at full strenth.

Them ol Docs dont like to over treat patients if possible. all that FIRST DO NO HARM N SH!T. STUFF..



<< Previous
Bullboard Posts
Next >>